Sarepta Therapeutics, Inc. — Director's Dealing 2012

Nov 8, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Sarepta Therapeutics, Inc. (SRPT)
CIK: 0000873303
Period of Report: 2012-11-05

Reporting Person: Mahatme Sandesh (Senior Vice President, CFO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-11-05	Stock Option (right to buy)	$23.85	A	150000	Disposed	2022-11-05	Common Stock (150000)	Direct
2012-11-05	Stock Appreciation Right	$23.85	A	100000	Disposed	2022-11-05	Common Stock (100000)	Direct

Footnotes

F1: 25% of the shares subject to the option vest on the first anniversary measured from November 5, 2012 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest in thirty-six (36) successive and equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.

F2: 25% of the shares subject to the stock appreciation right (the "SAR") vest on the first anniversary measured from November 5, 2012 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest in thirty-six (36) successive and equal monthly installments thereafter, such that 100% of the shares subject to the SAR will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.